The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Solifenacin Succinate Market Research Report 2025
Synopsis
It is mainly used to treat an overactive bladder.
The global Solifenacin Succinate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Solifenacin Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Solifenacin Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Solifenacin Succinate include Astellas Pharma, Sun Pharmaceutical Industries, Tapi Teva, Enantiotech and Guobang Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solifenacin Succinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solifenacin Succinate.
Report Scope
The Solifenacin Succinate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solifenacin Succinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solifenacin Succinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Sun Pharmaceutical Industries
Tapi Teva
Enantiotech
Guobang Pharma
Segment by Type
≥ 99%
＜ 99%
Segment by Application
Tablet
Capsule
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Solifenacin Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Solifenacin Succinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
It is mainly used to treat an overactive bladder.
The global Solifenacin Succinate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Solifenacin Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Solifenacin Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Solifenacin Succinate include Astellas Pharma, Sun Pharmaceutical Industries, Tapi Teva, Enantiotech and Guobang Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Solifenacin Succinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solifenacin Succinate.
Report Scope
The Solifenacin Succinate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Solifenacin Succinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solifenacin Succinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma
Sun Pharmaceutical Industries
Tapi Teva
Enantiotech
Guobang Pharma
Segment by Type
≥ 99%
＜ 99%
Segment by Application
Tablet
Capsule
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Solifenacin Succinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Solifenacin Succinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Solifenacin Succinate Market Overview
1.1 Product Overview and Scope of Solifenacin Succinate
1.2 Solifenacin Succinate Segment by Type
1.2.1 Global Solifenacin Succinate Market Value Comparison by Type (2024-2030)
1.2.2 ≥ 99%
1.2.3 ＜ 99%
1.3 Solifenacin Succinate Segment by Application
1.3.1 Global Solifenacin Succinate Market Value by Application: (2024-2030)
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Other
1.4 Global Solifenacin Succinate Market Size Estimates and Forecasts
1.4.1 Global Solifenacin Succinate Revenue 2019-2030
1.4.2 Global Solifenacin Succinate Sales 2019-2030
1.4.3 Global Solifenacin Succinate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Solifenacin Succinate Market Competition by Manufacturers
2.1 Global Solifenacin Succinate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Solifenacin Succinate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Solifenacin Succinate Average Price by Manufacturers (2019-2024)
2.4 Global Solifenacin Succinate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Solifenacin Succinate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Solifenacin Succinate, Product Type & Application
2.7 Solifenacin Succinate Market Competitive Situation and Trends
2.7.1 Solifenacin Succinate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Solifenacin Succinate Players Market Share by Revenue
2.7.3 Global Solifenacin Succinate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Solifenacin Succinate Retrospective Market Scenario by Region
3.1 Global Solifenacin Succinate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Solifenacin Succinate Global Solifenacin Succinate Sales by Region: 2019-2030
3.2.1 Global Solifenacin Succinate Sales by Region: 2019-2024
3.2.2 Global Solifenacin Succinate Sales by Region: 2025-2030
3.3 Global Solifenacin Succinate Global Solifenacin Succinate Revenue by Region: 2019-2030
3.3.1 Global Solifenacin Succinate Revenue by Region: 2019-2024
3.3.2 Global Solifenacin Succinate Revenue by Region: 2025-2030
3.4 North America Solifenacin Succinate Market Facts & Figures by Country
3.4.1 North America Solifenacin Succinate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Solifenacin Succinate Sales by Country (2019-2030)
3.4.3 North America Solifenacin Succinate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Solifenacin Succinate Market Facts & Figures by Country
3.5.1 Europe Solifenacin Succinate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Solifenacin Succinate Sales by Country (2019-2030)
3.5.3 Europe Solifenacin Succinate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Solifenacin Succinate Market Facts & Figures by Country
3.6.1 Asia Pacific Solifenacin Succinate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Solifenacin Succinate Sales by Country (2019-2030)
3.6.3 Asia Pacific Solifenacin Succinate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Solifenacin Succinate Market Facts & Figures by Country
3.7.1 Latin America Solifenacin Succinate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Solifenacin Succinate Sales by Country (2019-2030)
3.7.3 Latin America Solifenacin Succinate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Solifenacin Succinate Market Facts & Figures by Country
3.8.1 Middle East and Africa Solifenacin Succinate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Solifenacin Succinate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Solifenacin Succinate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Solifenacin Succinate Sales by Type (2019-2030)
4.1.1 Global Solifenacin Succinate Sales by Type (2019-2024)
4.1.2 Global Solifenacin Succinate Sales by Type (2025-2030)
4.1.3 Global Solifenacin Succinate Sales Market Share by Type (2019-2030)
4.2 Global Solifenacin Succinate Revenue by Type (2019-2030)
4.2.1 Global Solifenacin Succinate Revenue by Type (2019-2024)
4.2.2 Global Solifenacin Succinate Revenue by Type (2025-2030)
4.2.3 Global Solifenacin Succinate Revenue Market Share by Type (2019-2030)
4.3 Global Solifenacin Succinate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Solifenacin Succinate Sales by Application (2019-2030)
5.1.1 Global Solifenacin Succinate Sales by Application (2019-2024)
5.1.2 Global Solifenacin Succinate Sales by Application (2025-2030)
5.1.3 Global Solifenacin Succinate Sales Market Share by Application (2019-2030)
5.2 Global Solifenacin Succinate Revenue by Application (2019-2030)
5.2.1 Global Solifenacin Succinate Revenue by Application (2019-2024)
5.2.2 Global Solifenacin Succinate Revenue by Application (2025-2030)
5.2.3 Global Solifenacin Succinate Revenue Market Share by Application (2019-2030)
5.3 Global Solifenacin Succinate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma
6.1.1 Astellas Pharma Corporation Information
6.1.2 Astellas Pharma Description and Business Overview
6.1.3 Astellas Pharma Solifenacin Succinate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Solifenacin Succinate Product Portfolio
6.1.5 Astellas Pharma Recent Developments/Updates
6.2 Sun Pharmaceutical Industries
6.2.1 Sun Pharmaceutical Industries Corporation Information
6.2.2 Sun Pharmaceutical Industries Description and Business Overview
6.2.3 Sun Pharmaceutical Industries Solifenacin Succinate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Industries Solifenacin Succinate Product Portfolio
6.2.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.3 Tapi Teva
6.3.1 Tapi Teva Corporation Information
6.3.2 Tapi Teva Description and Business Overview
6.3.3 Tapi Teva Solifenacin Succinate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tapi Teva Solifenacin Succinate Product Portfolio
6.3.5 Tapi Teva Recent Developments/Updates
6.4 Enantiotech
6.4.1 Enantiotech Corporation Information
6.4.2 Enantiotech Description and Business Overview
6.4.3 Enantiotech Solifenacin Succinate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Enantiotech Solifenacin Succinate Product Portfolio
6.4.5 Enantiotech Recent Developments/Updates
6.5 Guobang Pharma
6.5.1 Guobang Pharma Corporation Information
6.5.2 Guobang Pharma Description and Business Overview
6.5.3 Guobang Pharma Solifenacin Succinate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Guobang Pharma Solifenacin Succinate Product Portfolio
6.5.5 Guobang Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Solifenacin Succinate Industry Chain Analysis
7.2 Solifenacin Succinate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Solifenacin Succinate Production Mode & Process
7.4 Solifenacin Succinate Sales and Marketing
7.4.1 Solifenacin Succinate Sales Channels
7.4.2 Solifenacin Succinate Distributors
7.5 Solifenacin Succinate Customers
8 Solifenacin Succinate Market Dynamics
8.1 Solifenacin Succinate Industry Trends
8.2 Solifenacin Succinate Market Drivers
8.3 Solifenacin Succinate Market Challenges
8.4 Solifenacin Succinate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
